PT Tempo Scan Pacific Tbk (TSPC.JK)
Jakarta · IDR · Industrials · Conglomerates
IDR 2,480 (+0.41%) as of
Key statistics
- Market cap
- 11.18T
- P/E (TTM)
- 7.63
- EPS (TTM)
- 325.12
- Dividend yield
- 6.07%
- 52-week range
- 2,240.00 – 3,220.00
- Beta
- 0.13
- Revenue (TTM)
- 14.52T
- Profit margin
- 10.19%
- Volume
- 212.90k
About PT Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk engages in the pharmaceuticals, personal care and cosmetics, and distribution services businesses in Indonesia and internationally. The company operates through Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services segments. It is involved in the pharmaceutical and medical devices trading; manufacture of soaps, herbal products, powder milk, food and beverages, and plastic packaging; and manufacturing and trading of consumer products, cosmetics, and household products. The company sells its products under the Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Vidoran, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, Total Care, and ULTIMA II brands. It also engages in the construction and rental of buildings; Trading, fresh milk processing, livestock, and agriculture; cosmetics retailer and e-commerce; advertising and promotion, research and development, and information technology and communication network systems services; and procurement, distribution, and marketing activities. The company was formerly known as PT Scanchemie. PT Tempo Scan Pacific Tbk was founded in 1970 and is based in Jakarta, Indonesia. The company operates as a subsidiary of PT Bogamulia Nagadi.
- Sector
- Industrials
- Industry
- Conglomerates
- Headquarters
- Jakarta, Indonesia
- Employees
- 4,390
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.